Skip to main content
Fig. 3 | BMC Microbiology

Fig. 3

From: Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection

Fig. 3

Efficacy of gelatin hydrogels containing paenipeptin analogue 1, clarithromycin, or their combination against carbapenem-resistant Acinetobacter baumannii AR0063 in murine skin wound infection (n = 8, equal number of female and male CD-1 mice). A Treatments at 4 h post infection; B Treatments at 20 h post infection. PBS: hydrogel in PBS without antimicrobials (negative control); Paen1: hydrogel with 0.1 mg/ml paenipeptin analogue 1; CLR: hydrogel with 0.1 mg/ml clarithromycin; Paen1+ CLR: hydrogel with 0.1 mg/ml paenipeptin analogue 1 and 0.1 mg/ml clarithromycin. Means with different letters are significantly different between groups (p < 0.05)

Back to article page